North Carolina SB 335: Pharmacists/Test and Treat/Influenza and Strep.

Status: Passed 1st Reading (as of 2025-04-15)

State: North Carolina · Session: 2025 · Bill: SB 335

Subjects: BOARDS; DEFINITIONS; DHHS; DISEASES & HEALTH DISORDERS; HEALTH SERVICES; INSURANCE; INSURANCE, HEALTH; MEDICAL BOARD; OCCUPATIONS; PHARMACEUTICALS; PHARMACISTS & PHARMACIES; PHARMACY BOARD; PUBLIC; PUBLIC HEALTH; STATE EMPLOYEES; TESTING; TESTING SERVICES; STATE HEALTH DIRECTOR

Sponsors: Galey, Sawrey, Adcock, Burgin, Ford, Hise, Moffitt

Bill Text

GENERAL ASSEMBLY OF NORTH CAROLINA
SESSION 2025
S 4
SENATE BILL 335
Health Care Committee Substitute Adopted 4/2/25
Commerce and Insurance Committee Substitute Adopted 4/8/25
Fourth Edition Engrossed 4/10/25

Short Title: Pharmacists/Test and Treat/Influenza & Strep. (Public)
Sponsors:
Referred to:
March 20, 2025
*S335-v-4*
A BILL TO BE ENTITLED 1
AN ACT TO ALLOW PHARMACISTS TO TEST AND TREAT FOR CERTAIN ILLNESSES 2
WITH CERTAIN MEDICATIONS APPROVED BY THE BOARD OF PHARMACY, TO 3
PROVIDE FOR FAIR AND EQUITABLE REIMBURSEMENT OF HEALTH CARE 4
SERVICES OR PROCEDURES THAT ARE PERFORMED BY A PHARMACIST 5
WITHIN THAT PHARMACIST'S SCOPE OF PRACTICE AND THAT ARE 6
EQUIVALENT TO SERVICES PERFORMED BY OTHER HEALTH CARE 7
PROFESSIONALS, AND TO APPROPRIATE FUNDS TO THE DEPARTMENT OF 8
INSURANCE. 9
The General Assembly of North Carolina enacts: 10
SECTION 1.(a) G.S. 90-85.3 reads as rewritten: 11
"§ 90-85.3. Definitions. 12
... 13
(b2) "CLIA-waived test" means a laboratory test authorized by the Food and Drug 14
Administration and waived under the Clinical Laboratory Improvement Amendments of 1988. 15
(b3) "Clinical pharmacist practitioner" means a licensed pharmacist who meets the 16
guidelines and criteria for such title established by the joint subcommittee of the North Carolina 17
Medical Board and the North Carolina Board of Pharmacy and is authorized to enter into drug 18
therapy management agreements with physicians in accordance with the provisions of 19
G.S. 90-18.4. 20
...." 21
SECTION 1.(b) G.S. 90-85.3A reads as rewritten: 22
"§ 90-85.3A. Practice of pharmacy. 23
... 24
(b) A pharmacist may advise and educate patients and health care providers concerning 25
therapeutic values, content, uses, and significant problems of drugs and devices; assess, record, 26
and report adverse drug and device reactions; take and record patient histories relating to drug 27
and device therapy; administer drugs; monitor, record, and report drug therapy and device usage; 28
perform drug utilization reviews; and participate in drug and drug source selection and device 29
and device source selection as provided in G.S. 90-85.27 through G.S. 90-85.31. 30
... 31
(e) A pharmacist may order and perform a CLIA-waived test and initiate treatment 32
pursuant to the result of the CLIA-waived test for (i) influenza and (ii) streptococcus infections 33

General Assembly Of North Carolina Session 2025
Page 2 Senate Bill 335-Fourth Edition
in accordance with statewide protocols. A pharmacist shall not treat a health condition under this 1
section with any controlled substance classified in Schedules I through IV." 2
SECTION 1.(c) This section becomes effective October 1, 2025. 3
SECTION 2.(a) Article 3 of Chapter 58 of the General Statutes is amended by adding 4
a new section to read: 5
"§ 58-3-241. Healthcare services provided by pharmacists. 6
(a) The following definitions apply in this section: 7
(1) Healthcare provider. – Either of the following: 8
a. An individual who is licensed, certified, or otherwise authorized under 9
Chapter 90 of the General Statutes to provide healthcare services in 10
the ordinary course of business or practice of a profession or in an 11
approved education or training program. 12
b. A health care facility licensed under Chapter 131E or Chapter 122C of 13
the General Statutes and where healthcare services are provided to 14
patients. 15
(2) Healthcare services. – Any of the following health or medical procedures or 16
services rendered by a healthcare provider: 17
a. Testing, diagnosis, or treatment of a health condition, illness, injury, 18
or disease. This includes testing, diagnosis, or treatment rendered by a 19
pharmacist acting within the pharmacist's scope of practice. 20
b. Dispensing of drugs, medical devices, medical appliances, or medical 21
goods for the treatment of a health condition, illness, injury, or disease. 22
c. Administration of a vaccine or medication. 23
(3) Pharmacist. – An individual licensed to practice pharmacy under Article 4A 24
of Chapter 90 of the General Statutes or the relevant laws of another state. 25
(b) A health benefit plan offered by an insurer in this State shall cover healthcare services 26
provided by a pharmacist if all of the following conditions are met: 27
(1) The service or procedure was performed within the pharmacist's licensed 28
lawful scope of practice. 29
(2) The health benefit plan would have covered the service if the service or 30
procedure had been performed by another healthcare provider. 31
(c) The participation of a pharmacy in a drug benefit provider network of a health benefit 32
plan shall not satisfy any requirement that insurers offering health benefit plans include 33
pharmacists in medical benefit provider networks. 34
(d) An insurer shall accept a claim under this section regardless of whether it is submitted 35
by a pharmacist or a pharmacy submitting the claim on behalf of a pharmacist the pharmacy 36
employs or contracts with." 37
SECTION 2.(

View North Carolina SB 335 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.